Scott Adams, the mind behind the iconic 'Dilbert' comic strip, passed away Tuesday morning at the age of 68 following his fight with prostate cancer. His passing was confirmed by his ex-wife Shelly Miles during the time slated for Adams' regular Tuesday livestream, "Coffee with Scott Adams."
Adams publicly disclosed his cancer diagnosis in 2025 and engaged his followers in his treatment journey. As his health worsened, he moved to hospice care, signaling the severity of his condition. This emotional update was delivered by Miles, who struggled to maintain composure as she broke the news to Adams' audience. She expressed, "Unfortunately, this isn't good news... He's not with us right anymore."
The announcement included a final message from Adams, dated January 1, 2026, where he addressed his soundness of mind and decisions regarding his estate. Adams' statement also touched on a significant personal revelation. He disclosed his acceptance of Christianity, a decision shaped by his analytical nature. "I'm not a believer, but I have to admit, the risk-reward calculation for doing so looks so attractive to me. So here I go. I accept Jesus Christ as my Lord and Savior," he wrote.
Adams' acceptance of faith was influenced by his Christian friends and conveyed through a tweet by Libby Emmons. In recent broadcasts, he had hinted at this spiritual decision, though remaining candid about his prognosis, sharing that his recovery chances were virtually nonexistent. In his final weeks, Adams transformed his livestream into a call-in platform, fostering heartfelt exchanges with friends and supporters.
The outpouring of responses to Adams' death and his embrace of faith underscores the impact of his work and personal journey. 'Dilbert', which lampooned office life and corporate culture, became an essential read for many. Adams' legacy extends beyond the comic strip through his books and the candid discourse on his livestream.
Adams' struggle also highlighted issues surrounding experimental treatments, as he reached out to President Trump's administration for help in accessing care that insurance denied. This aspect of his journey underscores broader discussions on healthcare access and patient advocacy.
